FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 16:48:59 26/06/2024 BST | ||
| 0.013 EUR | +18.18% |
|
| Current month | +22.22% | ||
| 3 months | -97.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 0.013 | +18.18% |
| 25/06/24 | 0.011 | 0.00% |
| 24/06/24 | 0.011 | +10.00% |
| 21/06/24 | 0.01 | +25.00% |
| 20/06/24 | 0.008 | +14.29% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 04:48 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SV9UPZ |
| ISIN | DE000SV9UPZ6 |
| Date issued | 19/07/2023 |
| Strike | 61.83 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.28 € |
|---|---|
| Lowest since issue | 0.006 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
- Stock Market
- Certificates
- Certificat
